Polio Vaccination for Adults
Routine polio vaccination is NOT recommended for most U.S. adults over age 18, but unvaccinated or incompletely vaccinated adults at increased risk should complete a 3-dose IPV primary series, with only a single lifetime booster dose needed for those previously vaccinated who remain at ongoing risk 1, 2.
Who Needs Polio Vaccination as an Adult
Adults Requiring Vaccination
Adults at increased risk for poliovirus exposure include 1, 2:
- Travelers to areas where polio is epidemic or endemic
- Laboratory workers handling specimens that may contain polioviruses
- Healthcare workers with close contact to patients potentially excreting wild polioviruses
- Members of communities with active wild poliovirus disease
- Adults whose children will receive oral poliovirus vaccine (historical context)
- All unvaccinated or incompletely vaccinated U.S. adults (updated 2023 recommendation following New York outbreak) 2
Adults NOT Requiring Vaccination
Most U.S. adults residing domestically have minimal poliovirus exposure risk and are already immune from childhood vaccination 1.
Primary Vaccination Series for Unvaccinated Adults
Standard Schedule (Preferred)
For unvaccinated adults at increased risk 1, 3:
- Dose 1 and 2: 0.5 mL IPV given 4-8 weeks apart (or 1-2 months)
- Dose 3: 0.5 mL IPV given 6-12 months after dose 2
Adults without documentation should be considered unvaccinated 1.
Accelerated Schedules (When Time is Limited)
When protection is needed urgently before travel 1, 3:
- >8 weeks available: Give 3 doses at least 4 weeks apart
- 4-8 weeks available: Give 2 doses at least 4 weeks apart
- <4 weeks available: Give single dose (complete series later if risk continues)
The remaining doses should be administered at recommended intervals if the person remains at increased risk 1.
Incomplete Vaccination in Adults
Adults with fewer than 3 total doses of any polio vaccine (OPV, conventional IPV, or combination) should receive at least one 0.5 mL dose of IPV, with additional doses to complete the primary series if time permits 1, 3.
Key principle: Interruption of the schedule does not require restarting the series—simply continue where left off regardless of time elapsed 1.
Booster Dosing
Previously Vaccinated Adults at Ongoing Risk
Adults who completed a primary series (OPV or IPV) and remain at increased risk can receive one additional 0.5 mL dose of IPV 1, 3.
Critical limitation: Available data do NOT indicate need for more than a single lifetime booster dose with IPV for adults 1. This represents a major difference from childhood schedules and reflects the durability of adult immune responses.
Administration Details
Route and Site
- Route: Intramuscular (preferred) or subcutaneous 3
- Site in adults: Deltoid area 3
- Never administer intravenously 3
Concurrent Vaccination
IPV can be administered simultaneously with other adult vaccines using separate syringes at separate sites 1.
Contraindications and Precautions
Absolute Contraindications
Do NOT administer IPV to persons with 1:
- Severe allergic (anaphylactic) reaction to previous IPV dose
- Anaphylactic reaction to streptomycin, polymyxin B, or neomycin (IPV contains trace amounts)
Important Distinction on Antibiotic Allergies
Persons with non-anaphylactic reactions to these antibiotics (e.g., contact dermatitis) are NOT at increased risk and may be vaccinated 4.
Anaphylactic signs to assess: hives, swelling of mouth/throat, difficulty breathing, hypotension, shock 4.
Pregnancy
- Vaccination should be avoided on theoretical grounds (no documented adverse effects exist) 1
- However, if a pregnant woman is at increased risk and requires immediate protection, IPV can be administered according to standard adult schedules 1
- This represents a pragmatic exception when protection is urgently needed
Immunodeficiency
IPV is the ONLY polio vaccine recommended for immunodeficient persons and their household contacts 1. IPV administration is safe in this population, though protective immune response cannot be ensured 1.
Common Pitfalls to Avoid
Do not assume all adults are vaccinated: Adults without documentation should be considered unvaccinated 1
Do not give multiple boosters: Only one lifetime booster is indicated for previously vaccinated adults at ongoing risk 1
Do not restart interrupted series: Continue from where the patient left off regardless of time elapsed 1
Do not withhold from pregnant women at genuine risk: While theoretically avoided, IPV can be given when immediate protection is needed 1
Do not confuse non-anaphylactic antibiotic reactions with true contraindications: Only anaphylactic reactions to streptomycin, polymyxin B, or neomycin are contraindications 4
Safety Profile
No serious adverse events related to enhanced-potency IPV have been documented 1. The vaccine has an excellent safety profile in adults.